PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Half of prostate cancers could potentially benefit from new type of cancer drugs, U-M study finds

Study in cells finds PARP inhibitors promising in large subset of prostate cancers

2011-05-19
(Press-News.org) ANN ARBOR, Mich. — About half of prostate cancers have a genetic anomaly that appears to make tumor cells responsive to a new class of cancer-fighting drugs, a new study from the University of Michigan Comprehensive Cancer Center finds.

The drugs, called PARP inhibitors, are currently being tested in breast cancer patients with mutations in the BRCA1 and BRCA2 genes, which are found in up to 10 percent of all breast cancers.

Half of prostate cancers have a genomic rearrangement that causes the fusion of two genes called TMPRSS2 and ERG. This gene fusion, believed to be the triggering event of prostate cancer, was initially discovered in 2005 by U-M researchers led by Arul Chinnaiyan, M.D., Ph.D.

"This type of gene fusion occurs in about 50 percent of prostate cancers, but the genes involved have been notoriously difficult to target therapeutically. We found that instead of targeting the gene fusion product directly, we could block the function of critical interacting partners, such as PARP1," says Chinnaiyan, a Howard Hughes Medical Institute researcher, director of the Michigan Center for Translational Pathology and S.P. Hicks Professor of Pathology at the U-M Medical School.

Chinnaiyan is the senior author of the current study, which appears in the May 17 issue of Cancer Cell.

"Our studies suggest that the total population of patients who could benefit from PARP inhibition could be significantly expanded," says Chad Brenner, Ph.D. candidate at U-M, who is the first author on the study.

Working with prostate cancer models in cell lines and mice, researchers found that therapies using the PARP inhibitor Olaparib helped shrink tumors expressing the TMPRSS2:ERG gene fusion and blocked the ability of tumors to spread. Olaparib had no effect on tumors that did not have the gene fusion.

PARP inhibitors are not currently approved by the U.S. Food and Drug Administration, but initial trials in breast cancer patients indicate they can be administered safely and are well-tolerated.

Study authors Maha Hussain, M.D., and Felix Y. Feng, M.D., are currently working on two clinical trials based on these study findings to test if the TMPRSS2:ERG gene fusion could be used as to predict response to treatments, including a PARP inhibitor. These studies are not yet recruiting participants.

###

Prostate cancer statistics: 217,730 Americans will be diagnosed with prostate cancer this year and 32,050 will die from the disease, according to the American Cancer Society

Additional authors: Bushra Ateeq, Yong Li, Anastasia K. Yocum, Qi Cao, Irfan A. Asangani, Sonam Patel, Xiaoju Wang, Hallie Liang, Jindan Yu, Nallasivam Palanisamy, Javed Siddiqui, Wei Yan, Xuhong Cao, Rohit Mehra, Aaron Sabolch, Venkatesha Basrur, Robert J. Lonigro, Scott A. Tomlins, Christopher A. Maher, Kojo S.J. Elenitoba-Johnson, Kenneth J. Pienta, Sooryanarayana Varambally, all from U-M; Jun Yang, Nora M. Navone, from M.D. Anderson Cancer Center

Funding: National Institutes of Health, U-M Prostate Specialized Program in Research Excellence grant, Early Detection Research Network, U.S. Department of Defense, Prostate Cancer Foundation

Disclosure: The University of Michigan has received a patent on the detection of gene fusions in prostate cancer (US 7,718,369), on which Tomlins and Chinnaiyan are co-inventors. The diagnostic field of use has been licensed to Gen-Probe Inc. Chinnaiyan also has a sponsored research agreement with Gen-Probe. Gen-Probe has had no role in the design or experimentation of this study, nor has it participated in the writing of the manuscript.

Reference: Cancer Cell, Vol. 19, No. 5, pp. 664-678, May 17, 2011

Resources:
U-M Cancer AnswerLine, 800-865-1125
U-M Comprehensive Cancer Center, www.mcancer.org
Clinical trials at U-M, www.UMClinicalStudies.org

END



ELSE PRESS RELEASES FROM THIS DATE:

Closed Head Injuries Can Be Serious Consequence of Auto Accidents

2011-05-19
Head injuries can be classified in one of two ways, open and closed. Open, or penetrating, head wounds are what most of us think of when picturing common brain injuries. They occur when an object pierces the skull, and are usually easy to observe and detect. Closed head injuries, on the other hand, typically involve a blow from an object that does not break the skull. Closed head injuries are often difficult to diagnose, since they often evince no external signs. Yet, they can be just as damaging as their open counterparts. An article by Leonardo Rangel-Castilla, ...

Increase in risk of certain gastric cancer from heavy drinking

2011-05-19
The results from a very well-done meta-analysis support other data generated on the risk of alcohol consumption and gastric cancer – that is – that the risk may be real for heavy alcohol consumption but not for moderate intake. The type of gastric cancer relating to heavier alcohol intake in this study tended to be tumors involving the noncardia, but differences between the association with tumors of the gastric cardia were not significant. There was no increased risk of gastric cancer from alcohol intake among Asians; this may be due to their lower alcohol intake; ...

Marker identifies breast cancer patients likely to respond to tamoxifen

2011-05-19
PHILADELPHIA—Cancer researchers at the Kimmel Cancer Center at Jefferson and an international team of collaborators have discovered a biomarker in breast cancer that may help identify which women will respond to anti-estrogen therapy. The research appears in the May 16 online issue of the Journal of Clinical Oncology. Anti-estrogen drugs, most notably tamoxifen, are widely used in patients diagnosed with estrogen receptor-positive breast cancer. However, as many as a third of the women given tamoxifen fail to respond. In this new study, the investigators found ...

New study predicts risk of wetland habitat loss in southern United States

2011-05-19
Baylor University, in collaboration with the U.S Forest Service (USFS) Rocky Mountain Research Station, has developed a model that predicts the risk of wetland habitat loss based on local wetland features and characteristics of the landscape surrounding the wetland. The new model was used to predict the fate of wetland habitats over a 13-state area in the southern United States and was published in the journal Ecological Applications. "Because conservation resources are scarce, it is essential to focus conservation efforts on those geographic areas where the risks for ...

Karlsruhe invisibility cloak: Disappearing visibly

Karlsruhe invisibility cloak: Disappearing visibly
2011-05-19
"Seeing something invisible with your own eyes is an exciting experience," say Joachim Fischer and Tolga Ergin. For about one year, both physicists and members of the team of Professor Martin Wegener at KIT's Center for Functional Nanostructures (CFN) have worked on refining the structure of the Karlsruhe invisibility cloak to such an extent that it is also effective in the visible spectral range. In invisibility cloaks, light waves are guided by the material such that they leave the invisibility cloak again as if they had never been in contact with the object to be ...

Language learning: CMU researchers use video games to crack the speech code

2011-05-19
When we speak, our enunciation and pronunciation of words and syllables fluctuates and varies from person to person. Given this, how do infants decode all of the spoken sounds they hear to learn words and meanings? To replicate the challenges of learning language as an infant, Carnegie Mellon University's Lori Holt and Sung-Joo Lim and Stockholm University's Francisco Lacerda used video game training with a mock "alien" language. They discovered that listeners quickly recognize word-like units. They will present their findings at the Acoustical Society of America's ...

Facebook: Changing the Landscape of Texas Divorce

2011-05-19
A recent story shows the potential mischief that can be caused by simply having a Facebook page. Richard Leon Barton Jr. posted pictures of his wedding on his Facebook page. One problem. Technically, he wasn't divorced from his first wife. And she saw the pictures. He is now facing polygamy charges in Michigan. Apparently, he believed he was divorced from his first wife, Adina Quarto. While they had discussed divorce, and were separated, they had never finalized the divorce. He had "defriended" his first wife before he married his second, but Quarto came ...

Rainbows without pigments offer new defense against fraud

Rainbows without pigments offer new defense against fraud
2011-05-19
Scientists from the University of Sheffield have developed pigment-free, intensely coloured polymer materials, which could provide new, anti-counterfeit devices on passports or banknotes due to their difficulty to copy. The polymers do not use pigments but instead exhibit intense colour due to their structure, similar to the way nature creates colour for beetle shells and butterfly wings. These colours were created by highly ordered polymer layers, which the researchers produced using block copoylmers (an alloy of two different polymers). By mixing block copolymers ...

Columbia researchers work to prevent blindness from age-related macular degeneration

2011-05-19
NEW YORK – Slowing down the aggregation or "clumping" of vitamin A in the eye may help prevent vision loss caused by macular degeneration, research from Columbia University Medical Center has found. Rather than changing the way the eye processes vitamin A, a team of researchers led by Ilyas Washington, a professor in the department of ophthalmology at Columbia's Harkness Eye Institute, decided to focus on changing the structure of vitamin A itself. In turn, Dr. Washington and his lab have taken a novel step toward treating age-related macular degeneration (AMD), a top ...

Corporate Travel Agency Teplis Travel Announces Global Headquarters Move to New Atlanta Location

2011-05-19
Teplis Travel, a leading corporate travel agency, recently moved its corporate headquarters in Atlanta, GA to a new, nearby location in Atlanta's prestigious Central Perimeter area. Previously located on Perimeter Center Parkway, Teplis Travel's global headquarters is now in The Terraces South, part of a twin 11-story tower complex that is situated on a lush, wooded 25-acre site with a lake. At The Terraces tenants can enjoy the buildings' sunlit atriums, beautiful reflecting pools and fountains inside the facility and stunning views of downtown Atlanta. The property ...

LAST 30 PRESS RELEASES:

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

UNC-Chapel Hill study shows AI can dramatically speed up digitizing natural history collections

OYE Therapeutics closes $5M convertible note round, advancing toward clinical development

Membrane ‘neighborhood’ helps transporter protein regulate cell signaling

Naval aviator turned NPS doctoral student earns national recognition for applied quantum research

Astronomers watch stars explode in real time through new images

Carbon-negative building material developed at Worcester Polytechnic Institute published in matter

[Press-News.org] Half of prostate cancers could potentially benefit from new type of cancer drugs, U-M study finds
Study in cells finds PARP inhibitors promising in large subset of prostate cancers